IDSA is conducting a guideline prioritization process. Please take our short survey to help us determine which guidelines to update in 2019 or suggest new topics. The survey will be open through Tuesday, August 14. Thank you!

The American Board of Internal Medicine (ABIM) has several openings throughout ABIM governance, including the Board of Directors, Council, Specialty Boards, and Exam Committees, as well as newer initiatives such as the Knowledge Check-In Item-Writing Task Force.

The House Energy and Commerce Committee Health Subcommittee held a hearing last week on implementation of the Medicare Access and CHIP Reauthorization Act (MACRA) and the Merit-Based Incentive Payment System (MIPS).

The HIV community, led by the Act Now END AIDS Coalition, is developing a national blueprint to end AIDS as an epidemic.

FDA has issued draft guidance for implementing the Limited Population Antibacterial and Antifungal Drug (LPAD) Pathway, which is well aligned with the legislation enacted in 2016, spearheaded by IDSA, to establish this new pathway.

The House Energy and Commerce Committee has approved the Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization bill which includes a new provision spearheaded by IDSA to support the development of our public health workforce, including ID physicians.

Don’t miss The International Foundation for Alternative Research in AIDS (IFARA’s) Interview with HIVMA Clinical Fellows (2017-2018) Yury Parra, MD and Vanessa Rojas, MD at AIDS 2018. They talk about their work in HIV that resulted in being granted the award, funded by the IDSA Foundation, and what the fellowship means to them.